Research Article
Prevalence of Anxiety and Depression in Prostate Cancer Patients and Their Spouses: An Unaddressed Reality
Table 6
Relationship between primary treatment and stage of the disease with the possibility of the test being pathological.
| | HT | RP | RT | AS | | ST | UT | | Local. | L. adv. | Mtx | CRPC | |
| MAX-PC | 5/49 (10.2%) | 10/99 (10.1%) | 3/16 (18.75%) | 2/20 (10%) | 0.72 | 5/41 (12.2%) | 15/143 (10.5%) | 0.38 | 11/117 (10.2%) | 3/33 (9.09%) | 5/24 (20.8%) | 1/10 (10%) | 0.42 | HADS anxiety patient | 8/49 (16.3%) | 13/99 (13.13%) | 3/16 (18.7%) | 2/20 (10%) | 0.84 | 5/41 (12.2%) | 21/143 (14.7%) | 0.69 | 15/117 (12.8%) | 6/33 (18.8%) | 4/24 (16.6%) | 1/10 (10%) | 0.83 | HADS depression patient | 4/49 (8.16%) | 6/99 (6.06%) | 2/16 (12.5%) | 1/20 (5%) | 0.78 | 3/41 (7.3%) | 10/143 (6.9%) | 0.94 | 5/117 (4.2%) | 5/33 (15.1%) | 2/24 (8.3%) | 1/10 (10%) | 0.18 | PHQ patient | 5/49 (10.2%) | 8/99 (8.08%) | 2/16 (12.5%) | 2/20 (10%) | 0.93 | 5/41 (12.2%) | 12/143 (8.4%) | 0.41 | 7/117 (5.9%) | 4/33 (12.1%) | 4/24 (16.6%) | 2/10 (20%) | 0.19 |
|
|
( ) Pearson’s chi-square. ST: sequential treatment; UT: unique treatment; Local.: Localized PC; L. adv.: Locally advanced PC; MTX: metastatic PC; CRPC: castration resistant PC. |